GeneDx Holdings Corp. announced that on April 24, 2023, Rachel Sherman and Dennis Charney notified the Board that they will not stand for re-election as directors of the Company at the Company's 2023 annual meeting of stockholders (the “2023 Annual Meeting”) and will continue to serve as directors of the Company until the 2023 Annual Meeting . There are no disagreements between Dr. Sherman or Dr. Charney and the Company.